Alphina Therapeutics is a New Haven, Connecticut precision-oncology biotechnology company founded by experts in DNA repair and metabolic lethality. It develops next-generation antibody-drug conjugates (ADCs) that deliver potent NAMPT inhibitor payloads directly to tumors, designed to kill both dividing and non-dividing cancer cells, and pairs them… - View it on GitHub